These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5044782)

  • 1. Changes in antihemophilic factor (AHF, factor 8) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography.
    Bennett B; Ratnoff OD
    J Lab Clin Med; 1972 Aug; 80(2):256-63. PubMed ID: 5044782
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of factor-VIII-like antigen in haemophilic carriers and in patients with raised levels of biologically active factor VIII.
    Denson KW
    Br J Haematol; 1973 Apr; 24(4):451-61. PubMed ID: 4541400
    [No Abstract]   [Full Text] [Related]  

  • 4. Sources of variability in antihemophilic factor (factor VIII) procoagulant titers and precipitating antigen levels among obligate carriers of classic hemophilia.
    Jones PK; Ratnoff OD
    Blood; 1981 May; 57(5):928-32. PubMed ID: 6783148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of female carriers of hemophilia A through comparative determination of factor VIII activity and antigenicity].
    Parquet-Gernez A; Mazurier C; Goudemand M
    Pathol Biol (Paris); 1974 Nov; 22 suppl():37-42. PubMed ID: 4620094
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver.
    Green AJ; Ratnoff OD
    J Lab Clin Med; 1974 Feb; 83(2):189-97. PubMed ID: 4204243
    [No Abstract]   [Full Text] [Related]  

  • 9. Heckathorn's disease: variable functional dificiency of antihemophilic factor (factor VIII).
    Ratnoff OD; Lewis JH
    Blood; 1975 Aug; 46(2):161-73. PubMed ID: 1139038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The laboratory diagnosis of the carrier state for classic hemophilia.
    Ratnoff OD; Jones PK
    Ann Intern Med; 1977 May; 86(5):521-8. PubMed ID: 851299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of carriers of classic hemophilia. H. P. Smith Memorial Lecture.
    Ratnoff OD; Jones PK
    Am J Clin Pathol; 1976 Feb; 65(2):129-35. PubMed ID: 766603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient deficiency of antihemophilic factor (AHF) procoagulant and AHF-like antigen during administration of tetracycline.
    Stefanini M
    Am J Clin Pathol; 1980 Mar; 73(3):439-43. PubMed ID: 7361727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.
    Delgado J; Jimenez-Yuste V; Hernandez-Navarro F; Villar A
    Br J Haematol; 2003 Apr; 121(1):21-35. PubMed ID: 12670328
    [No Abstract]   [Full Text] [Related]  

  • 14. Carrier detection in classic hemophilia by combined measurement of immunologic (VIII AGN) and procoagulant (VIII AHF) activities.
    Eyster ME; Jones MB; Moore T; Delli-Bovi L
    Am J Clin Pathol; 1976 Jun; 65(6):975-81. PubMed ID: 937252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic properties of antihemophilic factor.
    Hoyer LW
    Prog Hematol; 1973; 8():191-221. PubMed ID: 4545112
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of VIII AHF response to adrenalin in hemophilia A.
    Eyster ME; Dranchak M; Haverstick J; Rogers JS
    Am J Hematol; 1977; 3():193-8. PubMed ID: 602937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor-VIII-related disorders and their relationship to pregnancy.
    Telfer MC; Chediak J
    J Reprod Med; 1977 Oct; 19(4):211-22. PubMed ID: 303293
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.
    Zimmerman TS; Ratnoff OD; Powell AE
    J Clin Invest; 1971 Jan; 50(1):244-54. PubMed ID: 5543879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic variations in factor VIII level.
    Giraudo LC
    Thromb Diath Haemorrh Suppl; 1968; 35():275-9. PubMed ID: 4953167
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical aspects of hemophilia and von Willebrand's disease.
    Ciavarella D; Counts RB
    Am J Med Technol; 1983 Dec; 49(12):850-4. PubMed ID: 6422754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.